Events

All members have the option of attending our various HTC-centric events which include:

  • Spring and Fall Member Meetings: Bring HTC staff together to connect, share best practices, and learn about key issues impacting HTCs.
  • Continuing Education (CE) Meetings: Bring nurses, pharmacists, physical therapists, and social workers together for discipline-specific continuing education, peer learning, and networking in support of the bleeding disorders community.
  • New HTC Staff Meeting: Brings staff new to their HTC or transitioning into a more operational role together to build knowledge, make connections, and better understand 340B and HTC operations.
  • Medical Providers & Business Administrators (MPBA) Meeting: HTC leaders come together to connect, collaborate, and plan for the future.
  • Member Webinars: Educate our members on HTC operations and organizational management, payer relations, regulations and legal updates, advocacy, and manufacturer updates.


Relevant non-member meetings and events within the bleeding disorder community are also listed here.

🟥 Member Webinar : Hemophilia Alliance Hosts – A Webinar from Novo Nordisk – Unmet Needs in Current Hemophilia Care: From Burdens to Breakthroughs

Date: Wednesday, December 18, 2024 Time: 1:00pm - 2:00pm ET         Title: Unmet Needs in Current Hemophilia Care: From Burdens to Breakthroughs Description and Session Objectives: To provide a clinical overview of the cost and treatment burden across all hemophilia types, the experience with current therapy, and unmet needs that may be Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from BioMarin on ROCTAVIAN: Improving Patient Outcomes – Latest Data & Support Initiatives

Date: Wednesday, February 19, 2025 Time: 1:00pm - 2:00pm ET       TITLE: ROCTAVIAN: Improving Patient Outcomes - Latest Data & Support Initiatives OBJECTIVE: Join us for a webinar on ROCTAVIAN (valoctocogene roxaparvovec), the groundbreaking gene therapy for severe hemophilia A. This webinar will delve into the latest clinical data updates, showcasing the long-term Read the full article...